Lilly(Eli) & Co

NYSE:LLY   3:59:59 PM EDT
145.58
-1.86 (-1.26%)
4:06:41 PM EDT: $145.70 +0.12 (+0.08%)
Products, Community

FDA Says Issued EUA For Eli Lilly's Investigational Monoclonal Antibody Therapy Bamlanivimab For Treatment Of Covid-19

Published: 11/09/2020 23:36 GMT
Eli Lilly and Co (LLY) - FDA Says Issued Eua for Eli Lilly's Investigational Monoclonal Antibody Therapy Bamlanivimab for Treatment of Covid-19.
FDA Says Authorizes Monoclonal Antibody Therapy Bamlanivimab for Treatment of Covid-19 in Adult and Pediatric Patients.